The global Clinical Biomarkers market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biomarkers are a class of markers related to cell growth and proliferation that have been proposed in recent years with the development of immunology and molecular biology techniques. Biomarkers can not only discuss the pathogenesis at the molecular level, but also have a unique advantage in accurately and sensitively evaluating early and low-level damage. They can provide early warning, which largely provides clinicians with auxiliary diagnosis Basis.
This report aims to provide a comprehensive presentation of the global market for Clinical Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Biomarkers. This report contains market size and forecasts of Clinical Biomarkers in global, including the following market information:
- Global Clinical Biomarkers Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Diagnostic Biomarkers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Clinical Biomarkers include Abbott Laboratories, Agilent Technologies, Inc., ALCEDIAG, Becton, Dickinson and Company, bioM?rieux S.A., Bio-Rad Laboratories, Inc., CENTOGENE N.V., F. Hoffmann-La Roche Ltd. and Enzo Biochem Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Clinical Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Biomarkers Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Clinical Biomarkers Market Segment Percentages, by Type, 2023 (%)
- Diagnostic Biomarkers
- Predictive Biomarkers
- Prognostic Biomarkers
Global Clinical Biomarkers Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Clinical Biomarkers Market Segment Percentages, by Application, 2023 (%)
- Research and Academic Laboratories
- Biopharmaceutical and Biotech Companies
- Diagnostic Centers
- Others
Global Clinical Biomarkers Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Clinical Biomarkers Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Clinical Biomarkers revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Clinical Biomarkers revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- Agilent Technologies, Inc.
- ALCEDIAG
- Becton, Dickinson and Company
- bioM?rieux S.A.
- Bio-Rad Laboratories, Inc.
- CENTOGENE N.V.
- F. Hoffmann-La Roche Ltd.
- Enzo Biochem Inc.
- Illumina, Inc.
- Myriad Genetics, Inc.
- Quest Diagnostics Incorporated
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clinical Biomarkers, market overview.
Chapter 2: Global Clinical Biomarkers market size in revenue.
Chapter 3: Detailed analysis of Clinical Biomarkers company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Clinical Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Clinical Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Clinical Biomarkers Overall Market Size
2.1 Global Clinical Biomarkers Market Size: 2023 VS 2030
2.2 Global Clinical Biomarkers Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Clinical Biomarkers Players in Global Market
3.2 Top Global Clinical Biomarkers Companies Ranked by Revenue
3.3 Global Clinical Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 Clinical Biomarkers Companies in Global Market, by Revenue in 2023
3.5 Global Companies Clinical Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical Biomarkers Players in Global Market
3.6.1 List of Global Tier 1 Clinical Biomarkers Companies
3.6.2 List of Global Tier 2 and Tier 3 Clinical Biomarkers Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Clinical Biomarkers Market Size Markets, 2023 & 2030
4.1.2 Diagnostic Biomarkers
4.1.3 Predictive Biomarkers
4.1.4 Prognostic Biomarkers
4.2 By Type - Global Clinical Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Clinical Biomarkers Revenue, 2019-2024
4.2.2 By Type - Global Clinical Biomarkers Revenue, 2025-2030
4.2.3 By Type - Global Clinical Biomarkers Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Clinical Biomarkers Market Size, 2023 & 2030
5.1.2 Research and Academic Laboratories
5.1.3 Biopharmaceutical and Biotech Companies
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application - Global Clinical Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Clinical Biomarkers Revenue, 2019-2024
5.2.2 By Application - Global Clinical Biomarkers Revenue, 2025-2030
5.2.3 By Application - Global Clinical Biomarkers Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Clinical Biomarkers Market Size, 2023 & 2030
6.2 By Region - Global Clinical Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Clinical Biomarkers Revenue, 2019-2024
6.2.2 By Region - Global Clinical Biomarkers Revenue, 2025-2030
6.2.3 By Region - Global Clinical Biomarkers Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Clinical Biomarkers Revenue, 2019-2030
6.3.2 US Clinical Biomarkers Market Size, 2019-2030
6.3.3 Canada Clinical Biomarkers Market Size, 2019-2030
6.3.4 Mexico Clinical Biomarkers Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Clinical Biomarkers Revenue, 2019-2030
6.4.2 Germany Clinical Biomarkers Market Size, 2019-2030
6.4.3 France Clinical Biomarkers Market Size, 2019-2030
6.4.4 U.K. Clinical Biomarkers Market Size, 2019-2030
6.4.5 Italy Clinical Biomarkers Market Size, 2019-2030
6.4.6 Russia Clinical Biomarkers Market Size, 2019-2030
6.4.7 Nordic Countries Clinical Biomarkers Market Size, 2019-2030
6.4.8 Benelux Clinical Biomarkers Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Clinical Biomarkers Revenue, 2019-2030
6.5.2 China Clinical Biomarkers Market Size, 2019-2030
6.5.3 Japan Clinical Biomarkers Market Size, 2019-2030
6.5.4 South Korea Clinical Biomarkers Market Size, 2019-2030
6.5.5 Southeast Asia Clinical Biomarkers Market Size, 2019-2030
6.5.6 India Clinical Biomarkers Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Clinical Biomarkers Revenue, 2019-2030
6.6.2 Brazil Clinical Biomarkers Market Size, 2019-2030
6.6.3 Argentina Clinical Biomarkers Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Clinical Biomarkers Revenue, 2019-2030
6.7.2 Turkey Clinical Biomarkers Market Size, 2019-2030
6.7.3 Israel Clinical Biomarkers Market Size, 2019-2030
6.7.4 Saudi Arabia Clinical Biomarkers Market Size, 2019-2030
6.7.5 UAE Clinical Biomarkers Market Size, 2019-2030
7 Clinical Biomarkers Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Clinical Biomarkers Major Product Offerings
7.1.4 Abbott Laboratories Clinical Biomarkers Revenue in Global Market (2019-2024)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Agilent Technologies, Inc.
7.2.1 Agilent Technologies, Inc. Company Summary
7.2.2 Agilent Technologies, Inc. Business Overview
7.2.3 Agilent Technologies, Inc. Clinical Biomarkers Major Product Offerings
7.2.4 Agilent Technologies, Inc. Clinical Biomarkers Revenue in Global Market (2019-2024)
7.2.5 Agilent Technologies, Inc. Key News & Latest Developments
7.3 ALCEDIAG
7.3.1 ALCEDIAG Company Summary
7.3.2 ALCEDIAG Business Overview
7.3.3 ALCEDIAG Clinical Biomarkers Major Product Offerings
7.3.4 ALCEDIAG Clinical Biomarkers Revenue in Global Market (2019-2024)
7.3.5 ALCEDIAG Key News & Latest Developments
7.4 Becton, Dickinson and Company
7.4.1 Becton, Dickinson and Company Company Summary
7.4.2 Becton, Dickinson and Company Business Overview
7.4.3 Becton, Dickinson and Company Clinical Biomarkers Major Product Offerings
7.4.4 Becton, Dickinson and Company Clinical Biomarkers Revenue in Global Market (2019-2024)
7.4.5 Becton, Dickinson and Company Key News & Latest Developments
7.5 bioM?rieux S.A.
7.5.1 bioM?rieux S.A. Company Summary
7.5.2 bioM?rieux S.A. Business Overview
7.5.3 bioM?rieux S.A. Clinical Biomarkers Major Product Offerings
7.5.4 bioM?rieux S.A. Clinical Biomarkers Revenue in Global Market (2019-2024)
7.5.5 bioM?rieux S.A. Key News & Latest Developments
7.6 Bio-Rad Laboratories, Inc.
7.6.1 Bio-Rad Laboratories, Inc. Company Summary
7.6.2 Bio-Rad Laboratories, Inc. Business Overview
7.6.3 Bio-Rad Laboratories, Inc. Clinical Biomarkers Major Product Offerings
7.6.4 Bio-Rad Laboratories, Inc. Clinical Biomarkers Revenue in Global Market (2019-2024)
7.6.5 Bio-Rad Laboratories, Inc. Key News & Latest Developments
7.7 CENTOGENE N.V.
7.7.1 CENTOGENE N.V. Company Summary
7.7.2 CENTOGENE N.V. Business Overview
7.7.3 CENTOGENE N.V. Clinical Biomarkers Major Product Offerings
7.7.4 CENTOGENE N.V. Clinical Biomarkers Revenue in Global Market (2019-2024)
7.7.5 CENTOGENE N.V. Key News & Latest Developments
7.8 F. Hoffmann-La Roche Ltd.
7.8.1 F. Hoffmann-La Roche Ltd. Company Summary
7.8.2 F. Hoffmann-La Roche Ltd. Business Overview
7.8.3 F. Hoffmann-La Roche Ltd. Clinical Biomarkers Major Product Offerings
7.8.4 F. Hoffmann-La Roche Ltd. Clinical Biomarkers Revenue in Global Market (2019-2024)
7.8.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.9 Enzo Biochem Inc.
7.9.1 Enzo Biochem Inc. Company Summary
7.9.2 Enzo Biochem Inc. Business Overview
7.9.3 Enzo Biochem Inc. Clinical Biomarkers Major Product Offerings
7.9.4 Enzo Biochem Inc. Clinical Biomarkers Revenue in Global Market (2019-2024)
7.9.5 Enzo Biochem Inc. Key News & Latest Developments
7.10 Illumina, Inc.
7.10.1 Illumina, Inc. Company Summary
7.10.2 Illumina, Inc. Business Overview
7.10.3 Illumina, Inc. Clinical Biomarkers Major Product Offerings
7.10.4 Illumina, Inc. Clinical Biomarkers Revenue in Global Market (2019-2024)
7.10.5 Illumina, Inc. Key News & Latest Developments
7.11 Myriad Genetics, Inc.
7.11.1 Myriad Genetics, Inc. Company Summary
7.11.2 Myriad Genetics, Inc. Business Overview
7.11.3 Myriad Genetics, Inc. Clinical Biomarkers Major Product Offerings
7.11.4 Myriad Genetics, Inc. Clinical Biomarkers Revenue in Global Market (2019-2024)
7.11.5 Myriad Genetics, Inc. Key News & Latest Developments
7.12 Quest Diagnostics Incorporated
7.12.1 Quest Diagnostics Incorporated Company Summary
7.12.2 Quest Diagnostics Incorporated Business Overview
7.12.3 Quest Diagnostics Incorporated Clinical Biomarkers Major Product Offerings
7.12.4 Quest Diagnostics Incorporated Clinical Biomarkers Revenue in Global Market (2019-2024)
7.12.5 Quest Diagnostics Incorporated Key News & Latest Developments
7.13 QIAGEN N.V.
7.13.1 QIAGEN N.V. Company Summary
7.13.2 QIAGEN N.V. Business Overview
7.13.3 QIAGEN N.V. Clinical Biomarkers Major Product Offerings
7.13.4 QIAGEN N.V. Clinical Biomarkers Revenue in Global Market (2019-2024)
7.13.5 QIAGEN N.V. Key News & Latest Developments
7.14 Thermo Fisher Scientific Inc.
7.14.1 Thermo Fisher Scientific Inc. Company Summary
7.14.2 Thermo Fisher Scientific Inc. Business Overview
7.14.3 Thermo Fisher Scientific Inc. Clinical Biomarkers Major Product Offerings
7.14.4 Thermo Fisher Scientific Inc. Clinical Biomarkers Revenue in Global Market (2019-2024)
7.14.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Clinical Biomarkers Market Opportunities & Trends in Global Market
Table 2. Clinical Biomarkers Market Drivers in Global Market
Table 3. Clinical Biomarkers Market Restraints in Global Market
Table 4. Key Players of Clinical Biomarkers in Global Market
Table 5. Top Clinical Biomarkers Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Clinical Biomarkers Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Clinical Biomarkers Revenue Share by Companies, 2019-2024
Table 8. Global Companies Clinical Biomarkers Product Type
Table 9. List of Global Tier 1 Clinical Biomarkers Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Clinical Biomarkers Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Clinical Biomarkers Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Clinical Biomarkers Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Clinical Biomarkers Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Clinical Biomarkers Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Clinical Biomarkers Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Clinical Biomarkers Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Clinical Biomarkers Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Clinical Biomarkers Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Clinical Biomarkers Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Clinical Biomarkers Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Clinical Biomarkers Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Clinical Biomarkers Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Clinical Biomarkers Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Clinical Biomarkers Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Clinical Biomarkers Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Clinical Biomarkers Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Clinical Biomarkers Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Clinical Biomarkers Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Clinical Biomarkers Revenue, (US$, Mn), 2025-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Clinical Biomarkers Product Offerings
Table 32. Abbott Laboratories Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Agilent Technologies, Inc. Company Summary
Table 35. Agilent Technologies, Inc. Clinical Biomarkers Product Offerings
Table 36. Agilent Technologies, Inc. Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 37. Agilent Technologies, Inc. Key News & Latest Developments
Table 38. ALCEDIAG Company Summary
Table 39. ALCEDIAG Clinical Biomarkers Product Offerings
Table 40. ALCEDIAG Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 41. ALCEDIAG Key News & Latest Developments
Table 42. Becton, Dickinson and Company Company Summary
Table 43. Becton, Dickinson and Company Clinical Biomarkers Product Offerings
Table 44. Becton, Dickinson and Company Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 45. Becton, Dickinson and Company Key News & Latest Developments
Table 46. bioM?rieux S.A. Company Summary
Table 47. bioM?rieux S.A. Clinical Biomarkers Product Offerings
Table 48. bioM?rieux S.A. Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 49. bioM?rieux S.A. Key News & Latest Developments
Table 50. Bio-Rad Laboratories, Inc. Company Summary
Table 51. Bio-Rad Laboratories, Inc. Clinical Biomarkers Product Offerings
Table 52. Bio-Rad Laboratories, Inc. Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 53. Bio-Rad Laboratories, Inc. Key News & Latest Developments
Table 54. CENTOGENE N.V. Company Summary
Table 55. CENTOGENE N.V. Clinical Biomarkers Product Offerings
Table 56. CENTOGENE N.V. Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 57. CENTOGENE N.V. Key News & Latest Developments
Table 58. F. Hoffmann-La Roche Ltd. Company Summary
Table 59. F. Hoffmann-La Roche Ltd. Clinical Biomarkers Product Offerings
Table 60. F. Hoffmann-La Roche Ltd. Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 61. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 62. Enzo Biochem Inc. Company Summary
Table 63. Enzo Biochem Inc. Clinical Biomarkers Product Offerings
Table 64. Enzo Biochem Inc. Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 65. Enzo Biochem Inc. Key News & Latest Developments
Table 66. Illumina, Inc. Company Summary
Table 67. Illumina, Inc. Clinical Biomarkers Product Offerings
Table 68. Illumina, Inc. Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 69. Illumina, Inc. Key News & Latest Developments
Table 70. Myriad Genetics, Inc. Company Summary
Table 71. Myriad Genetics, Inc. Clinical Biomarkers Product Offerings
Table 72. Myriad Genetics, Inc. Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 73. Myriad Genetics, Inc. Key News & Latest Developments
Table 74. Quest Diagnostics Incorporated Company Summary
Table 75. Quest Diagnostics Incorporated Clinical Biomarkers Product Offerings
Table 76. Quest Diagnostics Incorporated Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 77. Quest Diagnostics Incorporated Key News & Latest Developments
Table 78. QIAGEN N.V. Company Summary
Table 79. QIAGEN N.V. Clinical Biomarkers Product Offerings
Table 80. QIAGEN N.V. Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 81. QIAGEN N.V. Key News & Latest Developments
Table 82. Thermo Fisher Scientific Inc. Company Summary
Table 83. Thermo Fisher Scientific Inc. Clinical Biomarkers Product Offerings
Table 84. Thermo Fisher Scientific Inc. Clinical Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 85. Thermo Fisher Scientific Inc. Key News & Latest Developments
List of Figures
Figure 1. Clinical Biomarkers Segment by Type in 2023
Figure 2. Clinical Biomarkers Segment by Application in 2023
Figure 3. Global Clinical Biomarkers Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Clinical Biomarkers Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Clinical Biomarkers Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Clinical Biomarkers Revenue in 2023
Figure 8. By Type - Global Clinical Biomarkers Revenue Market Share, 2019-2030
Figure 9. By Application - Global Clinical Biomarkers Revenue Market Share, 2019-2030
Figure 10. By Type - Global Clinical Biomarkers Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Clinical Biomarkers Revenue Market Share, 2019-2030
Figure 12. By Application - Global Clinical Biomarkers Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Clinical Biomarkers Revenue Market Share, 2019-2030
Figure 14. By Region - Global Clinical Biomarkers Revenue Market Share, 2019-2030
Figure 15. By Country - North America Clinical Biomarkers Revenue Market Share, 2019-2030
Figure 16. US Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Clinical Biomarkers Revenue Market Share, 2019-2030
Figure 20. Germany Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 21. France Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Clinical Biomarkers Revenue Market Share, 2019-2030
Figure 28. China Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 32. India Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Clinical Biomarkers Revenue Market Share, 2019-2030
Figure 34. Brazil Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Clinical Biomarkers Revenue Market Share, 2019-2030
Figure 37. Turkey Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Clinical Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 41. Abbott Laboratories Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Agilent Technologies, Inc. Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. ALCEDIAG Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Becton, Dickinson and Company Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. bioM?rieux S.A. Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bio-Rad Laboratories, Inc. Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. CENTOGENE N.V. Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. F. Hoffmann-La Roche Ltd. Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Enzo Biochem Inc. Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Illumina, Inc. Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Myriad Genetics, Inc. Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Quest Diagnostics Incorporated Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. QIAGEN N.V. Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Thermo Fisher Scientific Inc. Clinical Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
